z-logo
Premium
Semiquantifiable angiogenesis parameters in association with the malignant transformation of oral leukoplakia
Author(s) -
Thiem Daniel G. E.,
Schneider Schamiem,
Venkatraman Narayan T.,
Kumar Vinay V.,
Brieger Jürgen,
Frerich Bernhard,
Kämmerer Peer W.
Publication year - 2017
Publication title -
journal of oral pathology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.887
H-Index - 83
eISSN - 1600-0714
pISSN - 0904-2512
DOI - 10.1111/jop.12544
Subject(s) - hyperkeratosis , medicine , leukoplakia , malignant transformation , dysplasia , angiogenesis , epithelial dysplasia , tongue , pathology , basal cell , microvessel , oral submucous fibrosis , vascular endothelial growth factor , oral and maxillofacial pathology , cancer , vegf receptors , dentistry
Background Aim of the study was to assess the role of angiogenesis in the process of malignant transformation of clinical diagnosed oral leucoplakia ( OL ). Materials and methods A total of 131 histological preparations [oral leukoplakia/hyperkeratosis without dysplasia ( OL ; n = 49), oral leukoplakia/hyperkeratosis with mild dysplasia ( OL ‐ SIN 1; n = 33), with moderate dysplasia ( OL ‐ SIN 2; n = 13) and leukoplakia‐derived oral squamous cell carcinoma ( OL ‐ OSCC ; n = 36)] were evaluated for microvessel density ( MVD ), vessel diameter as well as for vascular endothelial growth factor ( VEGF ‐A) expression. Data were compared within the groups. Results For MVD , there were significant differences between OL and OL ‐ SIN 2/ OL ‐ OSCC ( P < 0.05) and between OL ‐ SIN 1 and OL ‐ OSCC ( P < 0.05). For OL ‐ OSCC , vessel diameters were significantly increased compared with OL ( P < 0.05). Expression of VEGF ‐A increased significantly gradually from OL ‐ SIN 1 to OSCC (each P < 0.05). This was especially evident for lesions of the tongue when compared to the others. Conclusion Angiogenesis increases during the transition from OL through dysplasia to OL ‐ OSCC . In particular, OL ‐ OSCC s of the tongue, VEGF ‐A expression may be used for estimation of malignant progression of OL .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom